openPR Logo
Press release

OTC Vitamins & Dietary Supplements Market is set to Expand at 6.7% CAGR during the forecast period (2017-2022)

04-12-2021 08:47 PM CET | Health & Medicine

Press release from: Fact.MR

According to the recently conducted study by Fact.MR, the global OTC vitamins and dietary supplements market is set to expand at 6.7% CAGR during the forecast period (2017-2022) to surpass a valuation of US$ 97,688 Mn. OTC vitamin and dietary supplement products.

To remain ‘ahead’ of your competitors, request for a sample https://www.factmr.com/connectus/sample?flag=S&rep_id=61

Over-the-counter (OTC) vitamins and dietary supplements are sold directly to consumers without any medical prescription. In many countries, OTC vitamins and dietary supplement products are regulated to ensure that they are effective and safe when used. Drug regulatory bodies allow manufacturers to formulate vitamin ingredients or combination of ingredients that are well tolerated and do not pose any risk of side effects or reactions. In recent years, the healthcare sector has witness exponential growth, which has reflected positively on the global market for OTC vitamins and dietary supplements.

Sales of such products have also increased in emerging countries such as China, India and Brazil primarily owing to the growing consumer awareness regarding the health benefits of such products. Convenience of direct purchase, cost-efficiency and growing trends of self-treatment are additional factors expected fuel the growth of the market. Moreover, manufacturers are also concentrating on developing advanced product formulations in order to improve their functionalities.

Following insights from Fact.MR’s report on the global OTC vitamins and dietary supplements market will be crucial for market’s future growth

Among regions, North America is expected to remain one of the most lucrative market for OTC vitamins and dietary supplements between 2017 and 2022. The region currently commands for the highest value share of the global market as demand for various OTC drugs is on the rise particularly in the U.S. Asia Pacific excluding Japan (APEJ) is also projected to emerge as an attractive market for OTC vitamins and dietary supplements over 2022. In terms of revenue, the market in Europe is anticipated to command for over 31% share of the global market, by 2017-end.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=61

On the basis of functions, OTC vitamins and dietary supplements are being used majorly for maintaining general well-being of the body. The general well-being segment accounts for a large percentage of the overall market revenue.
In 2017 and beyond, pharmacies will continue to be the top OCT channel for sales of OTC vitamin products including capsules and tablets.

Over one-fourth revenue share of the global market is currently captured by the pharmacy OTC channel segment. Though, this OTC channel segment is expected to lose a small fraction of its revenue share over 2020, mainly due to emergence of new OCT channels such online retail and modern trade.

Sales of capsule based OTC vitamins and dietary supplements will continue to remain strong during the forecast period. By 2022-end, nearly US$ 32,891 Mn worth capsules are estimated to be sold across the globe.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/61/S

Competition Tracking

Key players profiled in the Fact.MR’s report include Dil Limited., Bactolac Pharmaceutical, Inc., Otsuka Holdings Co. Ltd., CSPC Pharmaceutical Group Limited., Reckitt Benckiser LLC, Sanofi S.A., Pfizer, Inc. Atrium Innovations, Inc., Lonza Group Ltd, Jubilant Life Sciences Limited, Archer Daniels Midland Company, Koninklijke DSM N.V., BASF SE, GlaxoSmithKline plc and DuPont.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com
Research Insight: https://www.factmr.com/report/61/otc-vitamins-dietary-supplements-market
Content Source: https://www.factmr.com/media-release/47/otc-vitamins-dietary-supplements-market

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Vitamins & Dietary Supplements Market is set to Expand at 6.7% CAGR during the forecast period (2017-2022) here

News-ID: 2269204 • Views:

More Releases from Fact.MR

Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players include Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharmaceuticals, IBA Group, IBA Radiopharma Solutions, Lantheus Medical Imaging
10-01-2025 | Health & Medicine
Fact.MR
Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players inclu …
The global muscle stimulators market is set for significant expansion, with its valuation expected to increase from USD 1.43 billion in 2025 to USD 2.92 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 7.4% over the forecast period from 2025 to 2035. The market's robust trajectory is driven by rising awareness of health and fitness, technological advancements in rehabilitation devices, and the increasing prevalence
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Becton, Dickinson and Company, Betterlifehealthcare Ltd., Cadwell Industries, Inc., Compumedics Ltd., GlaxoSmithKline, Inc., Hill-Rom Holdings
10-01-2025 | Health & Medicine
Fact.MR
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Be …
Fact.MR today unveiled its latest report on the Sleeping Aids Market, forecasting robust growth amid escalating sleep disorders, heightened stress levels, and a global push for restorative wellness solutions. Valued at USD 78.3 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching USD 131.3 billion by 2035. This trajectory reflects the market's pivotal role in addressing widespread insomnia, sleep
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; Salesforce; SAS; Oracle; Acoustic; Act-on Software; SendinBlue
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; …
The global marketing automation market is experiencing robust growth, valued at USD 6.83 billion in 2024 and forecasted to reach USD 26.68 billion by 2034. This expansion reflects a compound annual growth rate (CAGR) of 14.6% over the forecast period from 2024 to 2034. The surge is primarily driven by the escalating demand for targeted advertising, enhanced user retention, and data-backed strategies in digital marketing channels. As internet penetration and
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, Driven by Digital Transformation and Hybrid Work Trends
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, …
The global Integrated Workplace Management System (IWMS) market is experiencing significant growth, with projections indicating an increase from approximately USD 4 billion in 2024 to USD 10.6 billion by 2034, reflecting a compound annual growth rate (CAGR) of 10.2% over the period from 2025 to 2034. This expansion is attributed to the rising demand for automation in facility management, the adoption of digital workplace solutions, and the need for efficient

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to